0001437749-23-013010.txt : 20230508
0001437749-23-013010.hdr.sgml : 20230508
20230508160214
ACCESSION NUMBER: 0001437749-23-013010
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230502
FILED AS OF DATE: 20230508
DATE AS OF CHANGE: 20230508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CONKLING WILLIAM
CENTRAL INDEX KEY: 0001852018
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39780
FILM NUMBER: 23897622
MAIL ADDRESS:
STREET 1: C/O RAFAEL HOLDINGS, INC.
STREET 2: 520 BROAD ST
CITY: NEWARK
STATE: NJ
ZIP: 07102
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cyclo Therapeutics, Inc.
CENTRAL INDEX KEY: 0000922247
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 593029743
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6714 NW 16TH STREET, SUITE B
CITY: GAINESVILLE
STATE: FL
ZIP: 32653
BUSINESS PHONE: 386-418-8060
MAIL ADDRESS:
STREET 1: PO BOX 1180
CITY: ALACHUA
STATE: FL
ZIP: 32616-1180
FORMER COMPANY:
FORMER CONFORMED NAME: CTD HOLDINGS INC
DATE OF NAME CHANGE: 20000913
FORMER COMPANY:
FORMER CONFORMED NAME: CYCLODEXTRIN TECHNOLOGIES DEVELOPMENT INC
DATE OF NAME CHANGE: 19941012
3
1
rdgdoc.xml
FORM 3
X0206
3
2023-05-02
0
0000922247
Cyclo Therapeutics, Inc.
CYTH
0001852018
CONKLING WILLIAM
6714 NW 16TH STREET
SUITE B
GAINESVILLE
FL
32653
1
Common Stock
0
I
See Footnote
The reporting person is the Chief Executive Officer of Rafael Holdings, Inc., which holds 2,514,970 shares of common stock of the Issuer and a warrant to purchase an additional 2,514,970 shares of common stock of the Issuer. The reporting person disclaims beneficial ownership of the securities of the Issuer held by Rafael Holdings, Inc.
/s/ William Conkling
2023-05-08